Login / Signup

Real-world Impact of 3 and 4.5 mg Doses of Dulaglutide on Weight and Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus.

Amy DuongSamantha HeacockSarah AmeringLillian BrennanJineane VenciNicole M Acquisto
Published in: The Annals of pharmacotherapy (2023)
Titration from dulaglutide 1.5 to 3 mg resulted in significant reductions in weight and HbA1c after 24 weeks. Additional, statistically significant, reductions in weight and HbA1c were seen when patients were further titrated to dulaglutide 4.5 mg weekly.
Keyphrases
  • body mass index
  • weight loss
  • end stage renal disease
  • physical activity
  • weight gain
  • ejection fraction
  • chronic kidney disease
  • body weight
  • prognostic factors
  • peritoneal dialysis
  • red blood cell